Anderson v. Biegler GmbH

CourtDistrict Court, D. Colorado
DecidedAugust 8, 2025
Docket1:24-cv-01603
StatusUnknown

This text of Anderson v. Biegler GmbH (Anderson v. Biegler GmbH) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Anderson v. Biegler GmbH, (D. Colo. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Nina Y. Wang

Civil Action No. 24-cv-01603-NYW-SBP

JAMES C. ANDERSON, and ANDERSON PODIATRY CENTER, P.C.,

Plaintiffs,

v.

BIEGLER GMBH, and SOLACE ADVANCEMENT, LLC

Defendants.

ORDER

This matter is before the Court on the Defendant Biegler GmbH’s Motion to Dismiss Plaintiffs’ Complaint Under Fed. R. Civ. P. 12(b)(2), for Forum Non Conveniens, and Under Fed. R. Civ. P. 12(b)(6) (the “Motion to Dismiss”), [Doc. 34], and Plaintiffs’ Request for Judicial Notice of Adjudicative Facts (the “Motion for Judicial Notice”), [Doc. 41]. For the reasons set forth in this Order, the Motion for Judicial Notice and the Motion to Dismiss are respectfully GRANTED. BACKGROUND1 Plaintiff James C. Anderson (“Dr. Anderson”) is a physician practicing in Fort Collins, Colorado at Anderson Podiatry Center, P.C. (with Dr. Anderson, “Plaintiffs”). [Doc. 1 at ¶¶ 25–26]. Defendant Biegler GmbH (“Defendant” or “Biegler”) is an Austrian

1 The Court takes the following well-pleaded factual allegations from the Complaint, [Doc. 1], and accepts them as true for purposes of the Motion to Dismiss, see XMission, L.C. v. Fluent LLC, 955 F.3d 833, 836 (10th Cir. 2020). corporation with its principal place of business in Austria. [Id. at ¶ 28]. Plaintiffs allege that Biegler “was engaged in the manufacturing, sale, distribution and marketing” of a medical device called the “Stivax System,” also referenced as the “Stivax device.” [Id. at ¶¶ 1–2, 28]. The Stivax device is “a single use, battery-powered,

electrical nerve stimulator which is used for the stimulation of the vagus nerve via the ear.” [Id. at ¶ 3 (quotation omitted)]. Plaintiffs allege that Biegler and co-Defendant Solace Advancement, LLC (“Solace”)2 erroneously promoted the Stivax device as an implantable non-narcotic pain management medical device that was reimbursable under certain Medicare codes. [Id. at ¶¶ 8–9]. Plaintiffs allege that “Defendants sold thousands of Stivax devices throughout the United States and including into Colorado and touted themselves as the market leader of the purported industry.” [Id. at ¶ 10]. According to Plaintiffs, “Defendants instructed Dr. Anderson and Anderson Podiatry how to bill Medicare and other government healthcare payors for the Stivax device using codes that Defendants . . . knew to be improper for the Stivax device.” [Id. at ¶ 11].

In 2016, the United States Food and Drug Administration (“FDA”) granted approval for Biegler, which Plaintiffs allege was “responsible for the FDA approval to market the Stivax device in the Unites States,” to market the Stivax device as an “electro- acupuncture device.” [Id. at ¶¶ 50–52, 55]. Biegler engaged Solace as the United States- based importer and distributor of the Stivax device. [Id. at ¶¶ 24, 56]. Plaintiffs allege that Defendants engaged with a number of other non-parties to create the “Stivax System

2 Plaintiffs allege that Solace is a “dissolved Michigan limited liability company.” [Doc. 1 at ¶ 24]. Plaintiffs obtained a Clerk’s Entry of Default against Solace on July 25, 2024. See [Doc. 21]. Although a year has passed since the entry of default, Plaintiffs have not moved for default judgment against Solace. The Court addresses this below. Enterprise”: Biegler manufactured the device; Solace . . . imported and contracted with [non-party] Nightingale to distribute the Stivax device to medical providers; [non-party] NexMed fulfilled orders submitted by medical providers; and [non-parties] Haga, Nightingale, Dawkins and Burgess continued to mispresent the Stivax device through so-called presentations, training, education, and instructions to Plaintiffs and other providers.

[Id. at ¶ 81]. Plaintiffs “purchased hundreds of Stivax devices” and submitted claims for reimbursement to Medicare “using Stivax System Enterprise recommended [billing] codes” for implantable devices. [Id. at ¶¶ 77, 81, 85]. “Medicare claim[ed] at least $276,162.26 in overpayments made under” the erroneous codes. [Id. at ¶ 85]. Plaintiffs initiated this action on June 7, 2024. See [id.]. They assert six claims, each against both Defendants: (1) a civil claim under the Racketeer Influenced and Corrupt Organizations Act (“RICO”), 18 U.S.C. § 1964(c), [Doc. 1 at ¶¶ 127–37]; (2) a civil RICO conspiracy claim, [id. at ¶¶ 138–44]; (3) a fraudulent misrepresentation claim, [id. at ¶¶ 145–51]; (4) an intentional misrepresentation claim, [id. at ¶¶ 152–57]; (5) a civil conspiracy claim, [id. at ¶¶ 158–62]; and (6) a claim under the Colorado Consumer Protection Act, [id. at ¶¶ 163–74]. In the Motion to Dismiss, Biegler seeks dismissal of Plaintiffs’ claims for lack of personal jurisdiction, forum non conveniens, and for failure to state a claim. See [Doc. 34]. LEGAL STANDARDS Personal jurisdiction is “an essential element of the jurisdiction of a district court,” and without it, “the court is ‘powerless to proceed to an adjudication.’” Ruhrgas AG v. Marathon Oil Co., 526 U.S. 574, 584 (1999) (quoting Emps. Reinsurance Corp. v. Bryant, 299 U.S. 374, 382 (1937)). The plaintiff bears the burden of demonstrating a court’s personal jurisdiction over a defendant. Melea, Ltd. v. Jawer SA, 511 F.3d 1060, 1065 (10th Cir. 2007). There are two types of personal jurisdiction: specific jurisdiction and general jurisdiction. Specific jurisdiction exists if the lawsuit arises out of or relates to the

defendant’s contacts with the forum. Bristol-Myers Squibb Co. v. Superior Ct. of Cal., 582 U.S. 255, 262 (2017). General jurisdiction “permits a court to adjudicate any cause of action against” the defendant, “wherever arising, and whoever the plaintiff.” Brown v. Lockheed Martin Corp., 814 F.3d 619, 624 (2d Cir. 2016). In either case, due process requires that the defendant “have ‘minimum contacts’ with the forum . . ., such that having to defend a lawsuit there would not ‘offend traditional notions of fair play and substantial justice.’” Dudnikov v. Chalk & Vermilion Fine Arts, Inc., 514 F.3d 1063, 1070 (10th Cir. 2008) (quoting Int’l Shoe Co. v. Washington, 326 U.S. 310, 316 (1945)). In some instances, a foreign defendant has sufficient contacts with the United States as a whole “to justify the application of United States law and to satisfy federal

standards of forum selection,” but lacks sufficient contacts with any one state to render it subject to the jurisdiction of a state. Archangel Diamond Corp. Liquidating Tr. v. OAO Lukoil, 75 F. Supp. 3d 1343, 1362–63 (D. Colo. 2014) (quotation omitted), aff’d, 812 F.3d 799 (10th Cir. 2016). Rule 4(k)(2) was promulgated to close that loophole. Id. The rule states that [f]or a claim that arises under federal law, serving a summons or filing a waiver of service establishes personal jurisdiction over a defendant if (A) the defendant is not subject to jurisdiction in any state’s courts of general jurisdiction; and (B) exercising jurisdiction over the defendant would be consistent with the United States Constitution and laws.

Fed. R. Civ. P. 4(k)(2).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Employers Reinsurance Corp. v. Bryant
299 U.S. 374 (Supreme Court, 1937)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Ruhrgas Ag v. Marathon Oil Co.
526 U.S. 574 (Supreme Court, 1999)
Reed v. Bennett
312 F.3d 1190 (Tenth Circuit, 2002)
Tal v. Hogan
453 F.3d 1244 (Tenth Circuit, 2006)
Melea, Ltd. v. Jawer Sa
511 F.3d 1060 (Tenth Circuit, 2007)
Dudnikov v. Chalk & Vermilion Fine Arts, Inc.
514 F.3d 1063 (Tenth Circuit, 2008)
Synthes v. G.M. Dos Reis Jr. Ind. Com. De Equip. Medico
563 F.3d 1285 (Federal Circuit, 2009)
Goodyear Dunlop Tires Operations, S. A. v. Brown
131 S. Ct. 2846 (Supreme Court, 2011)
J. McIntyre Machinery, Ltd. v. Nicastro
131 S. Ct. 2780 (Supreme Court, 2011)
Grynberg v. Ivanhoe Energy, Inc.
490 F. App'x 86 (Tenth Circuit, 2012)
AST Sports Science, Inc. v. CLF Distribution Ltd.
514 F.3d 1054 (Tenth Circuit, 2008)
United States v. Jones
768 F.3d 1096 (Tenth Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Anderson v. Biegler GmbH, Counsel Stack Legal Research, https://law.counselstack.com/opinion/anderson-v-biegler-gmbh-cod-2025.